期刊文献+

左氧氟沙星序贯疗法治疗社区获得性肺炎疗效观察 被引量:4

Effect observation of levofloxacin sequential therapy in treatment of community acquired pneumonia
下载PDF
导出
摘要 目的:观察左氧氟沙星治疗社区获得性肺炎(CAP)的疗效.方法:将84名患者随机分为序贯疗法组和对照组,每组42人,两组患者均在给予退热、止咳、平喘等对症治疗的基础上,对照组给予左氧氟沙星持续静脉给药;序贯疗法组采用同类药物静脉滴注3~4d,症状明显改善后改用同类药物口服,两组总疗程均为10~15d.结果:对照组总有效率为92.9%(39/42),序贯疗法组总有效率为90.5%(38/42),两组比较差异无统计学意义(P〉0.05);对照组平均住院时间(11.5± 2.3)d,序贯疗法组平均住院时间(6.3± 2.4)d,两组比较有统计学意义(P〈0.05).对照组发生不良反应28.6%(12/42),序贯疗法组发生不良反应11.9%(5/42),两者比较有统计学意义(P〈0.05).结论:应用左氧氟沙星序贯疗法治疗CAP,是一种经济、有效的治疗方法,具有临床可行性,但在临床应用中要注意选择有效的口服抗生素,并掌握合适的时机. Objective: To observe curative effect of levofloxacin in treatment of community acquired pneumonia (CAP). Meth- ods :84 patients were randomly divided into sequential therapy group and control group with 42 cases in each group. Based on the treat- ment for fever, cough, asthma and the like, the cases in control group were continuously intravenously injected with levofloxacin, whereas those in sequential group were intravenously dripped with the similar drug. When the symptoms were improved significantly, the two groups orally took the similar drug. the total course of treatment was both lO-15d. Results: The total effective rates of control group and sequential group were 92.9% (39/42) and 90.5% (38/42) , respectively; there was no significant difference between the two groups (P〉0.05). The mean hospitalization times of control group and sequential group were ( 11.5 ±2.3 ) d and (6.3±2.4) d, respectively; there was a significant difference between the two groups (P〈0. 05). The adverse reaction rates of control group and se- quential group were 28.6% (12/42) and 11.9% (5/42), respectively; there was a significant difference between the two groups (P 〈0.05). Conclusions: The levofloxacin sequential therapy for treating CAP is an economic and effective method and has the clinical feasibility; however, it should pay attention to choose effective oral antibiotic and use it in the right time.
作者 胡凤君
出处 《中国民康医学》 2013年第23期18-19,共2页 Medical Journal of Chinese People’s Health
关键词 左氧氟沙星 序贯疗法 肺炎 Levofloxacin Sequential therapy Pneumonia
  • 相关文献

参考文献4

二级参考文献29

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2孔晓东.药物经济学:概念、方法和应用[J].国外医学(药学分册),1994,21(1):13-18. 被引量:429
  • 3宋秉鹏,丁玉峰.药物经济学概述[J].药物流行病学杂志,1996,5(3):179-183. 被引量:306
  • 4刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 5Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 6de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 7Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 8Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 9Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 10Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.

共引文献3100

同被引文献24

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部